{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:38:57Z","timestamp":1793047137413,"version":"4.5.0"},"reference-count":154,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Transplant."],"abstract":"<jats:p>Up to 90% of the global population has been infected with cytomegalovirus (CMV), a herpesvirus that remains latent for the lifetime of the host and drives immune dysregulation. CMV is a critical risk factor for poor outcomes after solid organ transplant, though lung transplant recipients (LTR) carry the highest risk of CMV infection, and CMV-associated comorbidities compared to recipients of other solid organ transplants. Despite potent antivirals, CMV remains a significant driver of chronic lung allograft dysfunction (CLAD), re-transplantation, and death. Moreover, the extended utilization of CMV antiviral prophylaxis is not without adverse effects, often necessitating treatment discontinuation. Thus, there is a critical need to understand the immune response to CMV after lung transplantation. This review identifies key elements of each arm of the CMV immune response and highlights implications for lung allograft tolerance and injury. Specific attention is paid to cellular subsets of adaptive and innate immune cells that are important in the lung during CMV infection and reactivation. The concept of heterologous immune responses is reviewed in depth, including how they form and how they may drive tissue- and allograft-specific immunity. Other important objectives of this review are to detail the emerging role of NK cells in CMV-related outcomes, in addition to discussing perturbations in CMV immune function stemming from pre-existing lung disease. Finally, this review identifies potential mechanisms whereby CMV-directed treatments may alter the cellular immune response within the allograft.<\/jats:p>","DOI":"10.3389\/frtra.2024.1388393","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T20:41:33Z","timestamp":1718224893000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Innate and adaptive effector immune drivers of cytomegalovirus disease in lung transplantation: a double-edged sword"],"prefix":"10.3389","volume":"3","author":[{"given":"Reena","family":"Bharti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nri.2016.38","article-title":"T cell responses to cytomegalovirus","volume":"16","author":"Klenerman","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/978-3-319-28797-3_24","article-title":"Cytomegalovirus infection after stem cell transplantation","author":"Hakki","year":"2016","journal-title":"Transpl Infect: Fourth Edition"},{"key":"B3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/path.4437","article-title":"The pathogenesis of human cytomegalovirus","volume":"235","author":"Griffiths","year":"2015","journal-title":"J Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.chom.2010.06.014","article-title":"Viral latency and its regulation: lessons from the \u03b3-herpesviruses","volume":"8","author":"Speck","year":"2010","journal-title":"Cell Host Microbe"},{"key":"B6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s13665-020-00246-y","article-title":"Human cytomegalovirus prophylaxis and treatment in lung transplantation in the current era","volume":"9","author":"Mullane","year":"2020","journal-title":"Curr Pulmonol Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/QCO.0000000000000107","article-title":"Cytomegalovirus","volume":"27","author":"Griffiths","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1111\/ajt.13791","article-title":"The cell biology of cytomegalovirus: implications for transplantation","volume":"16","author":"Kaminski","year":"2016","journal-title":"Am J Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/ajt.15183","article-title":"Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: a paired kidney analysis","volume":"19","author":"Leeaphorn","year":"2019","journal-title":"Am J Transplant"},{"key":"B10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1440-1843.2012.02196.x","article-title":"Lung transplant infection","volume":"18","author":"Burguete","year":"2013","journal-title":"Respirology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.6061\/clinics\/2015(07)09","article-title":"Cytomegalovirus infection in transplant recipients","volume":"70","author":"Azevedo","year":"2015","journal-title":"Clinics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21926\/obm.transplant.2102145","article-title":"Cytomegalovirus in lung transplant","volume":"5","author":"Rosenheck","year":"2021","journal-title":"OBM Transplant"},{"key":"B14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/978-3-540-77349-8_22","article-title":"Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing","author":"Streblow","year":"2008","journal-title":"Hum Cytomegalovirus"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1086\/522433","article-title":"Cytomegalovirus reactivation in\u201d immunocompetent\u201d patients: a call for scientific prophylaxis","volume":"196","author":"Cook","year":"2007","journal-title":"J Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00408-022-00551-0","article-title":"Cytomegalovirus infection is associated with development of chronic lung allograft dysfunction","volume":"200","author":"Bennett","year":"2022","journal-title":"Lung"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.3390\/v6052038","article-title":"Characterization of cytomegalovirus lung infection in non-HIV infected children","volume":"6","author":"Restrepo-Gualteros","year":"2014","journal-title":"Viruses"},{"key":"B18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.healun.2022.10.014","article-title":"The human cytomegalovirus-specific and UL40-mediated imprint in the natural killer cell repertoire is associated with antibody-mediated rejection in lung transplant recipients","volume":"42","author":"Vietzen","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1093\/cid\/cis212","article-title":"Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective","volume":"54","author":"Kraft","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1111\/j.1600-6143.2011.03663.x","article-title":"Cytomegalovirus replication within the lung allograft is associated with bronchiolitis obliterans syndrome","volume":"11","author":"Paraskeva","year":"2011","journal-title":"Am J Transplant"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-07004-8","article-title":"Association between active cytomegalovirus infection and lung fibroproliferation in adult patients with acute respiratory distress syndrome: a retrospective study","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S399","DOI":"10.1016\/j.healun.2022.01.1562","article-title":"Incidence of post-transplant cytomegalovirus viremia in patients receiving lungs after ex vivo lung perfusion","volume":"41","author":"Ribeiro","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"B23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1164\/rccm.201805-0825OC","article-title":"Impaired cytomegalovirus immunity in idiopathic pulmonary fibrosis lung transplant recipients with short telomeres","volume":"199","author":"Popescu","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fcimb.2020.00130","article-title":"Cytomegalovirus latency and reactivation: an intricate interplay with the host immune response","volume":"10","author":"Forte","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/rmv.666","article-title":"Structure of influenza virus ribonucleoprotein complexes and their packaging into virions","volume":"20","author":"Noda","year":"2010","journal-title":"Rev Med Virol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/CMR.00043-19","article-title":"Progress and challenges in the prevention, diagnosis, and management of cytomegalovirus infection in transplantation","volume":"34","author":"Limaye","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0966-842X(03)00149-5","article-title":"Models of HCMV latency and reactivation","volume":"11","author":"Streblow","year":"2003","journal-title":"Trends Microbiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1111\/j.1462-5822.2005.00598.x","article-title":"Human cytomegalovirus expresses novel microRNAs during productive viral infection","volume":"7","author":"Dunn","year":"2005","journal-title":"Cell Microbiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"9065","DOI":"10.1128\/JVI.00961-08","article-title":"Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication","volume":"82","author":"Wang","year":"2008","journal-title":"J Virol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1371\/journal.ppat.0030163","article-title":"A human cytomegalovirus-encoded microRNA regulates expression of multiple viral genes involved in replication","volume":"3","author":"Grey","year":"2007","journal-title":"PLoS Pathog"},{"key":"B31","doi-asserted-by":"publisher","first-page":"10684","DOI":"10.1128\/JVI.01292-09","article-title":"Analysis of human cytomegalovirus-encoded microRNA activity during infection","volume":"83","author":"Stern-Ginossar","year":"2009","journal-title":"J Virol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e88531","DOI":"10.1371\/journal.pone.0088531","article-title":"Comprehensive analysis of human cytomegalovirus microRNA expression during lytic and quiescent infection","volume":"9","author":"Shen","year":"2014","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1004881","DOI":"10.1371\/journal.ppat.1004881","article-title":"Human cytomegalovirus miR-UL112-3p targets TLR2 and modulates the TLR2\/IRAK1\/NF\u03baB signaling pathway","volume":"11","author":"Landais","year":"2015","journal-title":"PLoS Pathog"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02897.x","article-title":"Cytomegalovirus in solid organ transplant recipients","volume":"9","author":"Humar","year":"2009","journal-title":"Am J Transplant"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5360","DOI":"10.1128\/jvi.67.9.5360-5366.1993","article-title":"Lungs are a major organ site of cytomegalovirus latency and recurrence","volume":"67","author":"Balthesen","year":"1993","journal-title":"J Virol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3947\/ic.2013.45.3.260","article-title":"Cytomegalovirus infections in solid organ transplantation: a review","volume":"45","author":"Ramanan","year":"2013","journal-title":"Infect Chemother"},{"key":"B37","doi-asserted-by":"publisher","first-page":"971156","DOI":"10.3389\/fimmu.2022.971156","article-title":"Diagnosis and treatment for the early stage of cytomegalovirus infection during hematopoietic stem cell transplantation","volume":"13","author":"Cui","year":"2022","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1128\/CMR.00015-13","article-title":"Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation","volume":"26","author":"Razonable","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1086\/319225","article-title":"Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients","volume":"32","author":"Singh","year":"2001","journal-title":"Clin Infect Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/331269a0","article-title":"Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens","volume":"331","author":"Beck","year":"1988","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.15753.1","article-title":"Cytomegalovirus infection and progressive differentiation of effector-memory T cells","volume":"7","author":"Pardieck","year":"2018","journal-title":"F1000Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-8-407","article-title":"Early monitoring of the human polyomavirus BK replication and sequencing analysis in a cohort of adult kidney transplant patients treated with basiliximab","volume":"8","author":"Anzivino","year":"2011","journal-title":"Virol J"},{"key":"B43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S2213-2600(14)70124-9","article-title":"Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation","volume":"2","author":"Stuart","year":"2014","journal-title":"Lancet Respir Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1183\/13993003.00308-2016","article-title":"Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive","volume":"48","author":"Newton","year":"2016","journal-title":"Eur Respir J"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/j.1600-6143.2010.03114.x","article-title":"Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients","volume":"10","author":"\u00c5sberg","year":"2010","journal-title":"Am J Transplant"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e1302","DOI":"10.1093\/cid\/ciaa1189","article-title":"Immunosuppressive agents and infectious risk in transplantation: managing the \u201cnet state of immunosuppression\u201d","volume":"73","author":"Roberts","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s13337-021-00728-w","article-title":"In-depth summary over cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation recipients","volume":"32","author":"Karami","year":"2021","journal-title":"Virusdisease"},{"key":"B48","doi-asserted-by":"publisher","first-page":"343","DOI":"10.15386\/cjmed-587","article-title":"Cytomegalovirus infection in immunosuppressed patients after kidney transplantation","volume":"89","author":"Luscalov","year":"2016","journal-title":"Clujul Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1111\/ajt.14886","article-title":"Suppressed calcineurin-dependent gene expression identifies lung allograft recipients at increased risk of infection","volume":"18","author":"Greenland","year":"2018","journal-title":"Am J Transplant"},{"key":"B50","doi-asserted-by":"publisher","first-page":"11837","DOI":"10.1128\/JVI.01623-08","article-title":"Human cytomegalovirus glycoproteins gB and gH\/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans","volume":"82","author":"Vanarsdall","year":"2008","journal-title":"J Virol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"7094","DOI":"10.4049\/jimmunol.177.10.7094","article-title":"Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells","volume":"177","author":"Boehme","year":"2006","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"18021","DOI":"10.1073\/pnas.1907447116","article-title":"Human cytomegalovirus glycoprotein B variants affect viral entry, cell fusion, and genome stability","volume":"116","author":"Tang","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B54","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1189\/jlb.0311171","article-title":"Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization","volume":"90","author":"Romo","year":"2011","journal-title":"J Leukoc Biol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1074-7613(00)80014-X","article-title":"Other functions, other genes: alternative activation of antigen-presenting cells","volume":"10","author":"Goerdt","year":"1999","journal-title":"Immunity"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1099\/vir.0.81595-0","article-title":"Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules","volume":"87","author":"Sinzger","year":"2006","journal-title":"J Gen Virol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"5604","DOI":"10.4049\/jimmunol.1302608","article-title":"Cytomegalovirus enhances macrophage TLR expression and MyD88-mediated signal transduction to potentiate inducible inflammatory responses","volume":"193","author":"Smith","year":"2014","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4049\/jimmunol.182.1.477","article-title":"Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor","volume":"182","author":"Frascaroli","year":"2009","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"11963","DOI":"10.3389\/ti.2023.11963","article-title":"Cytomegalovirus cell-mediated immunity: ready for routine use?","volume":"36","author":"Bestard","year":"2023","journal-title":"Transpl Int"},{"key":"B60","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1084\/jem.20011149","article-title":"Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells","volume":"195","author":"Ferlazzo","year":"2002","journal-title":"J Exp Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1182\/blood-2005-07-2696","article-title":"Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction","volume":"107","author":"Pende","year":"2006","journal-title":"Blood"},{"key":"B62","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.chom.2013.02.003","article-title":"Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses","volume":"13","author":"Smith","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1260543","DOI":"10.3389\/fmicb.2023.1260543","article-title":"Diverse roles of lung macrophages in the immune response to influenza a virus","volume":"14","author":"Li","year":"2023","journal-title":"Front Microbiol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"861292","DOI":"10.3389\/fimmu.2022.861292","article-title":"Cyclosporine a regulates influenza a virus-induced macrophages polarization and inflammatory responses by targeting cyclophilin a","volume":"13","author":"Bai","year":"2022","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"521287","DOI":"10.3389\/fimmu.2020.00793","article-title":"Cytomegaloviruses and macrophages\u2014friends and foes from early on?","volume":"11","author":"Baasch","year":"2020","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1164\/rccm.200408-1129OC","article-title":"Innate immunity influences long-term outcomes after human lung transplant","volume":"171","author":"Palmer","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1164\/rccm.200303-447OC","article-title":"The role of innate immunity in acute allograft rejection after lung transplantation","volume":"168","author":"Palmer","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1164\/ajrccm\/145.5.1178","article-title":"Activation of macrophages and cytotoxic cells during cytomegalovirus pneumonia complicating lung transplantations","volume":"145","author":"Humbert","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"B69","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/TP.0000000000001065","article-title":"Intrapulmonary human cytomegalovirus replication in lung transplant recipients is associated with a rise of CCL-18 and CCL-20 chemokine levels","volume":"101","author":"Weseslindtner","year":"2017","journal-title":"Transplantation"},{"key":"B70","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1183\/09031936.06.00019405","article-title":"The role of interleukin-17 during acute rejection after lung transplantation","volume":"27","author":"Vanaudenaerde","year":"2006","journal-title":"Eur Respir J"},{"key":"B71","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.healun.2007.05.004","article-title":"Interleukin-17 and airway inflammation: a longitudinal airway biopsy study after lung transplantation","volume":"26","author":"Snell","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trim.2008.01.004","article-title":"Natural killer cells and lung transplantation, roles in rejection, infection, and tolerance","volume":"19","author":"Fildes","year":"2008","journal-title":"Transpl Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/MOT.0b013e32834254cf","article-title":"Natural killer cells in rejection and tolerance of solid organ allografts","volume":"16","author":"Benichou","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"key":"B74","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science (1979)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212345","article-title":"Natural killer cells in lung transplantation","author":"Calabrese","year":"2018","journal-title":"Thorax"},{"key":"B76","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev-immunol-101819-074948","article-title":"Natural killer cells: from innate to adaptive features","volume":"39","author":"Mujal","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fimmu.2016.00235","article-title":"\u201cNatural regulators\u201d: NK cells as modulators of T cell immunity","volume":"7","author":"Schuster","year":"2016","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1002\/1521-4141(2001010)31:10%3C3048::AID-IMMU3048%3E3.0.CO;2-1","article-title":"NK cell functions restrain T cell responses during viral infections","volume":"31","author":"Su","year":"2001","journal-title":"Eur J Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"key":"B80","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/cei.13292","article-title":"HLA-E: exploiting pathogen-host interactions for vaccine development","volume":"196","author":"Sharpe","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3389\/fimmu.2017.01317","article-title":"Elusive role of the CD94\/NKG2C NK cell receptor in the response to cytomegalovirus: novel experimental observations in a reporter cell system","volume":"8","author":"Pupuleku","year":"2017","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s002510050421","article-title":"Localization of five new Ly49 genes, including three closely related to Ly49c","volume":"48","author":"McQueen","year":"1998","journal-title":"Immunogenetics"},{"key":"B83","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1084\/jem.194.1.29","article-title":"Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H","volume":"194","author":"Daniels","year":"2001","journal-title":"J Exp Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"8826","DOI":"10.1073\/pnas.092258599","article-title":"Recognition of a virus-encoded ligand by a natural killer cell activation receptor","volume":"99","author":"Smith","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B85","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature07665","article-title":"Adaptive immune features of natural killer cells","volume":"457","author":"Sun","year":"2009","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.immuni.2019.04.009","article-title":"Cytomegalovirus infection drives avidity selection of natural killer cells","volume":"50","author":"Adams","year":"2019","journal-title":"Immunity"},{"key":"B87","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.immuni.2023.01.016","article-title":"Infection induces tissue-resident memory NK cells that safeguard tissue health","volume":"56","author":"Schuster","year":"2023","journal-title":"Immunity"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e2116588119","DOI":"10.1073\/pnas.2116588119","article-title":"Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients","volume":"119","author":"Ishiyama","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"B89","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","article-title":"Imprint of human cytomegalovirus infection on the NK cell receptor repertoire","volume":"104","author":"Gum\u00e1","year":"2004","journal-title":"Blood"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1182\/blood-2011-10-386995","article-title":"Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood","volume":"119","author":"Foley","year":"2012","journal-title":"J Am Soc Hematol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1182\/blood-2005-09-3682","article-title":"Expansion of CD94\/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts","volume":"107","author":"Gum\u00e1","year":"2006","journal-title":"Blood"},{"key":"B92","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41436-020-01077-7","article-title":"Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19","volume":"23","author":"Vietzen","year":"2021","journal-title":"Genet Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/infdis\/jix608","article-title":"NKG2C deletion is a risk factor for human cytomegalovirus viremia and disease after lung transplantation","volume":"217","author":"Vietzen","year":"2018","journal-title":"J Infect Dis"},{"key":"B94","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/TP.0000000000002450","article-title":"NKG2C natural killer cells in bronchoalveolar lavage are associated with cytomegalovirus viremia and poor outcomes in lung allograft recipients","volume":"103","author":"Calabrese","year":"2019","journal-title":"Transplantation"},{"key":"B95","doi-asserted-by":"publisher","first-page":"105340","DOI":"10.1016\/j.isci.2022.105340","article-title":"The establishment of a cytomegalovirus-specific CD8+ T-cell threshold by kinetic modeling for the prediction of post-hemopoietic stem cell transplant reactivation","volume":"25","author":"Zhang","year":"2022","journal-title":"iScience"},{"key":"B96","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.virusres.2009.04.026","article-title":"NF-\u03baB and phosphatidylinositol 3-kinase activity mediates the HCMV-induced atypical M1\/M2 polarization of monocytes","volume":"144","author":"Chan","year":"2009","journal-title":"Virus Res"},{"key":"B97","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1128\/jvi.55.2.264-273.1985","article-title":"Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs","volume":"55","author":"Reddehase","year":"1985","journal-title":"J Virol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1600-6143.2012.04282.x","article-title":"High-quality CMV-specific CD4+ memory is enriched in the lung allograft and is associated with mucosal viral control","volume":"13","author":"Akulian","year":"2013","journal-title":"Am J Transplant"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1086\/339963","article-title":"Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype","volume":"185","author":"Khan","year":"2002","journal-title":"J Infect Dis"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.3389\/fimmu.2018.02692","article-title":"Defining memory CD8 T cell","volume":"9","author":"Martin","year":"2018","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nm0402-379","article-title":"Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections","volume":"8","author":"Appay","year":"2002","journal-title":"Nat Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1365-2567.2010.03386.x","article-title":"Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+ CD45RA+ CD27\u2212 T cells: the potential involvement of interleukin-7 in this process","volume":"132","author":"Libri","year":"2011","journal-title":"Immunology"},{"key":"B103","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2217\/fvl.12.8","article-title":"The immune response to human CMV","volume":"7","author":"La Rosa","year":"2012","journal-title":"Future Virol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1600-6143.2005.01212.x","article-title":"CMV-specific CD8+ T-cell dynamics in the blood and the lung allograft reflect viral reactivation following lung transplantation","volume":"6","author":"Westall","year":"2006","journal-title":"Am J Transplant"},{"key":"B105","doi-asserted-by":"publisher","first-page":"546","DOI":"10.4049\/jimmunol.181.1.546","article-title":"Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection","volume":"181","author":"Pipeling","year":"2008","journal-title":"J Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1016\/j.healun.2023.02.1525","article-title":"CMV-expanded, phenotypically heterogenous CD8 TEMRA differentially associate with viral control and allograft outcomes","volume":"42","author":"Pickering","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"B107","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/TP.0000000000001097","article-title":"CMV immunoglobulins for the treatment of CMV infections in thoracic transplant recipients","volume":"100","author":"Schulz","year":"2016","journal-title":"Transplantation"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.healun.2020.08.014","article-title":"Cytomegalovirus replication is associated with enrichment of distinct \u03b3\u03b4 T cell subsets following lung transplantation: a novel therapeutic approach?","volume":"39","author":"Stankovic","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"B109","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3389\/fimmu.2014.00601","article-title":"Cancer immunotherapy using \u03b3\u03b4 T cells: dealing with diversity","volume":"5","author":"Scheper","year":"2014","journal-title":"Front Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"119","DOI":"10.7150\/ijbs.7823","article-title":"\u03b3\u03b4 T cells and their potential for immunotherapy","volume":"10","author":"Wu","year":"2014","journal-title":"Int J Biol Sci"},{"key":"B111","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3389\/fimmu.2015.00371","article-title":"Recent advances in gamma\/delta T cell biology: new ligands, new functions, and new translational perspectives","volume":"6","author":"Kabelitz","year":"2015","journal-title":"Front Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-immunol-032713-120216","article-title":"\u03b3\u03b4 T cells: first line of defense and beyond","volume":"32","author":"Chien","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/bmt.2015.335","article-title":"Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression","volume":"51","author":"Guan","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B114","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1086\/322843","article-title":"Cytomegalovirus infection in transplant recipients resolves when circulating \u03b3\u03b4 T lymphocytes expand, suggesting a protective antiviral role","volume":"184","author":"Lafarge","year":"2001","journal-title":"J Infect Dis"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e1004702","DOI":"10.1371\/journal.ppat.1004702","article-title":"\u03b3\u03b4 T cells confer protection against murine cytomegalovirus (MCMV)","volume":"11","author":"Khairallah","year":"2015","journal-title":"PLoS Pathog"},{"key":"B116","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1002\/eji.201343690","article-title":"Adoptive transfer of cytomegalovirus-specific effector CD 4+ T cells provides antiviral protection from murine CMV infection","volume":"43","author":"Jeitziner","year":"2013","journal-title":"Eur J Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"e3634","DOI":"10.1371\/journal.pone.0003634","article-title":"Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation","volume":"3","author":"Widmann","year":"2008","journal-title":"PLoS One"},{"key":"B118","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fcimb.2020.00202","article-title":"The CD4+ T cell response to human cytomegalovirus in healthy and immunocompromised people","volume":"10","author":"Lim","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fimmu.2017.00019","article-title":"Cytotoxic CD4 T cells\u2014friend or foe during viral infection?","volume":"8","author":"Juno","year":"2017","journal-title":"Front Immunol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1084\/jem.20121517","article-title":"Revealing the role of CD4+ T cells in viral immunity","volume":"209","author":"Sant","year":"2012","journal-title":"J Exp Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nri3152","article-title":"Expanding roles for CD4+ T cells in immunity to viruses","volume":"12","author":"Swain","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"682334","DOI":"10.3389\/fimmu.2021.682334","article-title":"Approaches for controlling antibody-mediated allograft rejection through targeting B cells","volume":"12","author":"Matsuda","year":"2021","journal-title":"Front Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI70084","article-title":"B cells mediate chronic allograft rejection independently of antibody production","volume":"124","author":"Zeng","year":"2014","journal-title":"J Clin Invest"},{"key":"B124","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1189\/jlb.0713386","article-title":"The two faces of heterologous immunity: protection or immunopathology","volume":"95","author":"Sharma","year":"2014","journal-title":"J Leukoc Biol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1128\/CVI.00214-09","article-title":"Age-dependent association between low frequency of CD27\/CD28 expression on pp65 CD8+ T cells and cytomegalovirus replication after transplantation","volume":"16","author":"Cantis\u00e1n","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0167-5699(98)01299-7","article-title":"A very high level of crossreactivity is an essential feature of the T-cell receptor","volume":"19","author":"Mason","year":"1998","journal-title":"Immunol Today"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.4049\/jimmunol.142.5.1710","article-title":"Virus-induced polyclonal cytotoxic T lymphocyte stimulation","volume":"142","author":"Yang","year":"1989","journal-title":"J Immunol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/00007890-199402150-00018","article-title":"Respiratory viral infections aggravate airway damage caused by chronic rejection in rat lung allografts","volume":"57","author":"Winter","year":"1994","journal-title":"Transplantation"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/eji.201546179","article-title":"Coordinated expansion of both memory T cells and NK cells in response to CMV infection in humans","volume":"46","author":"Bayard","year":"2016","journal-title":"Eur J Immunol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1002\/eji.202149188","article-title":"Identification of the predominant human NK cell effector subset mediating ADCC against HIV-infected targets coated with BNAbs or plasma from PLWH","volume":"51","author":"Tomescu","year":"2021","journal-title":"Eur J Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ajt.2022.10.006","article-title":"CD16+ natural killer cells in bronchoalveolar lavage are associated with antibody-mediated rejection and chronic lung allograft dysfunction","volume":"23","author":"Calabrese","year":"2023","journal-title":"Am J Transplant"},{"key":"B132","doi-asserted-by":"publisher","first-page":"7570","DOI":"10.1073\/pnas.112680099","article-title":"UL40-mediated NK evasion during productive infection with human cytomegalovirus","volume":"99","author":"Wang","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B133","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1099\/vir.0.80285-0","article-title":"Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in vivo","volume":"85","author":"Reeves","year":"2004","journal-title":"J Gen Virol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.3390\/ijms20163865","article-title":"Cytomegalovirus (CMV) pneumonitis: cell tropism, inflammation, and immunity","volume":"20","author":"Fonseca Brito","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B135","doi-asserted-by":"publisher","first-page":"7201","DOI":"10.1128\/JVI.72.9.7201-7212.1998","article-title":"Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates","volume":"72","author":"Holtappels","year":"1998","journal-title":"J Virol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1172\/JCI122083","article-title":"Bronchus-associated lymphoid tissue\u2013resident Foxp3+ T lymphocytes prevent antibody-mediated lung rejection","volume":"129","author":"Li","year":"2019","journal-title":"J Clin Invest"},{"key":"B137","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.healun.2021.11.012","article-title":"Lung transplant recipients with idiopathic pulmonary fibrosis have impaired alloreactive immune responses","volume":"41","author":"Wang","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.healun.2015.05.002","article-title":"Clinical outcomes of lung transplant recipients with telomerase mutations","volume":"34","author":"Tokman","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"B139","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"B140","doi-asserted-by":"publisher","first-page":"10332","DOI":"10.3389\/ti.2022.10332","article-title":"Cytomegalovirus management in solid organ transplant recipients: a pre-COVID-19 survey from the working group of the European society for organ transplantation","volume":"35","author":"Grossi","year":"2022","journal-title":"Transpl Int"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1111\/ajt.13684","article-title":"The \u201cABC\u201d of virus-specific T cell immunity in solid organ transplantation","volume":"16","author":"Sester","year":"2016","journal-title":"Am J Transplant"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/cid\/ciy706","article-title":"Maribavir for refractory or resistant cytomegalovirus infections in hematopoietic-cell or solid-organ transplant recipients: a randomized, dose-ranging, double-blind, phase 2 study","volume":"68","author":"Papanicolaou","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B143","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1111\/ajt.16718","article-title":"Letermovir in lung transplant recipients with cytomegalovirus infection: a retrospective observational study","volume":"21","author":"Veit","year":"2021","journal-title":"Am J Transplant"},{"key":"B144","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1097\/TP.0000000000001418","article-title":"Outcomes in transplant recipients treated with foscarnet for ganciclovir-resistant or refractory cytomegalovirus infection","volume":"100","author":"Avery","year":"2016","journal-title":"Transplantation"},{"key":"B145","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3390\/cancers14020412","article-title":"Valganciclovir as add-on therapy modifies the frequency of NK and NKT cell subpopulations in disseminated kaposi sarcoma patients","volume":"14","author":"Flores-Gonzalez","year":"2022","journal-title":"Cancers"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/infdis\/jir060","article-title":"Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy","volume":"203","author":"Hunt","year":"2011","journal-title":"J Infect Dis"},{"key":"B147","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/intimm\/dxx062","article-title":"Impact of donor and recipient human cytomegalovirus status on kidney transplantation","volume":"29","author":"Zieli\u0144ski","year":"2017","journal-title":"Int Immunol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1600-6143.2010.03405.x","article-title":"Polyfunctional cytomegalovirus-specific immunity in lung transplant recipients receiving valganciclovir prophylaxis","volume":"11","author":"Snyder","year":"2011","journal-title":"Am J Transplant"},{"key":"B149","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/j.1365-2362.2007.01881.x","article-title":"Cytomegalovirus hyperimmunoglobulin: mechanisms in allo-immune response in vitro","volume":"37","author":"Hoetzenecker","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"B150","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.intimp.2014.01.007","article-title":"T-cell inhibitory capacity of hyperimmunoglobulins is influenced by the production process","volume":"19","author":"van Gent","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"B151","first-page":"2013","article-title":"Combined cytomegalovirus prophylaxis in lung transplantation: effects on acute rejection, lymphocytic bronchitis\/bronchiolitis, and herpesvirus infections.","volume-title":"Transplantation Proceedings","author":"Solidoro","year":"2008"},{"key":"B152","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1111\/j.1600-6143.2005.01029.x","article-title":"Hepatitis B immunoglobulins inhibit dendritic cells and T cells and protect against acute rejection after liver transplantation","volume":"5","author":"Kwekkeboom","year":"2005","journal-title":"Am J Transplant"},{"key":"B153","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/cid\/ciy549","article-title":"Autologous adoptive T-cell therapy for recurrent or drug-resistant cytomegalovirus complications in solid organ transplant recipients: a single-arm open-label phase I clinical trial","volume":"68","author":"Smith","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B154","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1093\/infdis\/jiad593","article-title":"Human cytomegalovirus mRNA-1647 vaccine candidate elicits potent and broad neutralization and higher antibody-dependent cellular cytotoxicity responses than that of the partially effective gB\/MF59 vaccine","author":"Hu","year":"2023","journal-title":"medRxiv"}],"container-title":["Frontiers in Transplantation"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2024.1388393\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T20:41:38Z","timestamp":1718224898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2024.1388393\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":154,"alternative-id":["10.3389\/frtra.2024.1388393"],"URL":"https:\/\/doi.org\/10.3389\/frtra.2024.1388393","relation":{},"ISSN":["2813-2440"],"issn-type":[{"value":"2813-2440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,10]]},"article-number":"1388393"}}